Related Experiment Video
Updated: Jun 27, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
A composite-likelihood approach for identifying polymorphisms that are potentially directly associated with disease
Joanna M Biernacka1, Heather J Cordell
1Department of Health Sciences Research, Division of Biostatistics, Mayo Clinic, Rochester, MN 55905, USA. biernacka.joanna@mayo.edu
This study introduces a new statistical method for genetic analysis. Combining multiple single nucleotide polymorphisms (SNPs) improves the power to detect disease-associated genetic regions.
Area of Science:
- Genetics
- Statistical Genetics
- Bioinformatics
Background:
- Linkage analysis identifies regions associated with disease, but causal variants require further investigation.
- Candidate single nucleotide polymorphisms (SNPs) are tested individually to explain linkage signals, which can be inefficient.
Purpose of the Study:
- To develop a novel statistical method for genetic analysis that combines multiple candidate SNPs.
- To improve the power of detecting disease-associated loci compared to single SNP approaches.
Main Methods:
- A composite-likelihood approach is proposed to analyze two or more candidate SNPs simultaneously.
- The method tests whether the combined association of multiple SNPs explains the observed linkage signal.
Main Results:
- Simulations demonstrate that the proposed composite-likelihood method significantly increases statistical power.
- The new method outperforms traditional single SNP analysis in detecting causal variants.
Conclusions:
- Combining multiple candidate SNPs using a composite-likelihood approach is a more powerful strategy for genetic association studies.
- This method enhances the ability to identify disease-related genetic variants in complex regions.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Probability Laws
Single Nucleotide Polymorphisms-SNPs
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Principles of Pharmacogenetics: Types of Genetic Variants